Clinical Trials Logo
  1. Home
  2. Skin Cancer
  3. NCT03503240
  4. Details
NCT03503240 Clinical Trial

QI: Patient Satisfaction With Facial Appearance, Scar Outcome and Quality of Life After Skin Cancer Surgery

Skin Cancer Clinical Trial

Official title:
QI: Patient Satisfaction With Facial Appearance, Scar Outcome and Quality of Life After Skin Cancer Surgery

Clinical Trial Details — Status: Enrolling by invitation

Administrative data
NCT number NCT03503240
Other study ID # 18-168
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date April 6, 2018
Est. completion date April 2025

Study information
Verified date May 2024
Source Memorial Sloan Kettering Cancer Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to evaluate patient satisfaction and quality of life as it relates to skin cancer surgery. This research study involves taking a one-time survey online.

Recruitment information / eligibility
Status Enrolling by invitation
Enrollment 3000
Est. completion date April 2025
Est. primary completion date April 2025
Accepts healthy volunteers No
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria: - Patients = 18 years of age at the time of surgery. - Had a diagnosis of a cutaneous malignancy on the face - Cutaneous malignancy includes, but is not limited to basal cell carcinoma, squamous cell carcinoma, and melanoma - The face is defined as location in the following areas: forehead, temple, eyebrow, eyelids, cheek, nose, lips, chin, and ears. - Able to speak and read English - MSK Only Cross Sectional Study: Radiation therapy patients = 18 years of age who have received RT for skin cancer Exclusion Criteria: - Unable to speak and read English

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
United States Brigham and Women's Hospital (Data Collection Only) Boston Massachusetts
United States University of Texas Southwestern Medical Center at Dallas Dallas Texas
United States Memorial Sloan Kettering Cancer Center New York New York
United States University of Nebraska Medical Center Omaha Nebraska
United States UC Davis Comprehensive Cancer Center Sacramento California

Sponsors (1)
Lead Sponsor Collaborator
Memorial Sloan Kettering Cancer Center

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary number of patients satisfied with facial appearance Satisfaction with Facial Appearance Scale, Appearance-related Psychosocial Distress Scale and Adverse Effects Checklist using the FACE-Q Skin Cancer instrument. 1 year
Primary number of patients satisfied with scar outcome Appraisal of Scars Scale, Appearance-related Psychosocial Distress Scale and Adverse Effects Checklist using the FACE-Q Skin Cancer instrument. 1year
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02721459 - XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma Phase 1
Completed NCT03740815 - Feasibility of Serratus Plane Block Associated With Sedation in Axillary Dissection N/A
Recruiting NCT05779423 - Cryoablation+Ipilimumab+Nivolumab in Melanoma Phase 2
Terminated NCT01468818 - Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma Phase 2
Completed NCT01820234 - Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event N/A
Completed NCT00535769 - Evaluation of Adherence to Topical Agents: Applying Communication Technology to Improve Sunscreen Use Phase 0
Completed NCT00526032 - Melanoma Detection by Oblique-Incidence Optical Spectroscopy N/A
Completed NCT00588341 - Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection Phase 2
Active, not recruiting NCT01447199 - The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Enrolling by invitation NCT04758988 - AI Augmented Training for Skin Specialists N/A
Not yet recruiting NCT04534868 - Patient Acceptance And Satisfaction of Teledermoscopy In General Practice In a Belgian Rural Area N/A
Recruiting NCT04138342 - Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer Phase 1
Completed NCT03673917 - Cosmetology Students and Skin Cancer N/A
Recruiting NCT04341064 - Sun-safe Habits Intervention and Education Phase 3
Completed NCT04206995 - Cancer Sensing: Evaluation of Odour Sampling Techniques
Recruiting NCT05574101 - A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer Phase 2
Not yet recruiting NCT05860881 - Topical Sirolimus in Chemoprevention of Facial Squamous Cell Carcinomas in Solid Organ Transplant Recipients (SiroSkin) Phase 3
Completed NCT05146622 - Virtual Sun Safe Workplaces Ph I
Recruiting NCT05068310 - Applicability of a Cellular Resolution Full-field OCT Image System for Pigmented and Non-pigmented Skin Tumors
Recruiting NCT03889899 - Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia. N/A

External Links